Get started
Genenta Science S.p.A. logo

SAEN

NASDAQ

Genenta Science S.p.A.

SectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)IPO2021
Follow + get alerts
Website

Genenta Science S.p.A. (SAEN) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for SAEN in the last 30 days.

Genenta Science (Nasdaq: GNTA) is evolving into a next-generation strategic consolidator focused on privately held specialized companies operating in Italian national security-regulated sectors, with activities spanning cybersecurity, defense, aerospace, and biotechnology/biosecurity. Genenta holds a 19% equity interest in Sòphia High Tech and has an option to increase its ownership to 51% at a pre-agreed valuation.

Financial highlights

Full financials
Net income, FY2025
-€6.53M
Free cash flow, FY2025
-€6.88M
Cash
€5.53M

For fiscal 2025 (ended Dec 31, 2025), from SEC filings. Not investment advice.

Latest news

0 items

No recent news.

SAEN FAQ

8 questions
  • What does Genenta Science S.p.A. do?
    Genenta Science (Nasdaq: GNTA) is evolving into a next-generation strategic consolidator focused on privately held specialized companies operating in Italian national security-regulated sectors, with activities spanning cybersecurity, defense, aerospace, and biotechnology/biosecurity. Genenta holds a 19% equity interest in Sòphia High Tech and has an option to increase its ownership to 51% at a pre-agreed valuation.
  • Is SAEN profitable?
    No. Genenta Science S.p.A. reported a net loss of €6.53M for fiscal 2025 (ended Dec 31, 2025).
  • How much cash and debt does SAEN have?
    Genenta Science S.p.A. reported €5.53M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does SAEN stock trade?
    Genenta Science S.p.A. (SAEN) is listed on NASDAQ.
  • What sector and industry is SAEN in?
    Genenta Science S.p.A. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
  • When did Genenta Science S.p.A. go public?
    Genenta Science S.p.A. (SAEN) completed its IPO in 2021.
  • What companies are similar to SAEN?
    Notable peers in the same industry include AMGN (Amgen Inc.), ARGX (argenx SE), MRNA (Moderna Inc.), RVMD (Revolution Medicines Inc.), GILD (Gilead Sciences Inc.). Compare SAEN side-by-side with any of them on Quantisnow.
  • How can I track SAEN on Quantisnow?
    Quantisnow aggregates Genenta Science S.p.A.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SAEN to receive live email and push alerts on every new disclosure.